Brief: Essity Q2 Net Sales Down At Sek 34,185 Mln

Essity AB (publ)

17/07/2025 06:13

July 17 (Reuters) - Essity AB (publ) ESSITYa.ST:

Q2 ORGANIC SALES GROWTH AMOUNTED TO 1.9%, OF WHICH VOLUME ACCOUNTED FOR 0.2% AND PRICE/MIX 1.7%

Q2 NET SALES DECREASED 6.6% TO SEK 34,185M (36,617)

Q2 EBITA EXCLUDING. IAC DECREASED 13% TO SEK 4,693M (5,398)

QUARTER WAS DOMINATED BY A WEAK ECONOMY AND AN UNCERTAIN EXTERNAL ENVIRONMENT, YIELDING LIMITED VOLUME GROWTH.

HIGHER SALES PRICES OFFSET INCREASED COSTS OF GOODS SOLD, INCLUDING TRADE TARIFFS.

LIMITED VOLUME GROWTH RESULTED IN LOWER COST COVERAGE

SEEING GOOD EFFECTS OF SEVERAL GROWTH INITIATIVES, FOR EXAMPLE IN JOBST LYMPHOLOGY, CUTIMED ADVANCED WOUND CARE

Q2 NET SALES SEK 34,185MLN VERSUS IBES ESTIMATE SEK 34,798 MILLION

Q2 ADJUSTED EBITA SEK 4,693MLN VERSUS IBES ESTIMATE SEK 4,859 MILLION

HIGHER SALES PRICES  AND VOLUMES HAD A POSITIVE IMPACT ON EARNINGS

THE  COSTS OF GOODS SOLD INCREASED, MAINLY DUE TO HIGHER RAW  MATERIAL AND DISTRIBUTION COSTS, INCLUDING TRADE TARIFFS

Source text: ID:nWkr97WLNQ

Further company coverage: [ESSITYa.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))